http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202144425-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7e2b9a11a3f71d165e7dd72230437a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f41ad3e3eb895fb77774c608c6e8eeb7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ecf5e04cff1408fb713e224b7f03c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243c1070d594ef423ffc5b63b0498614
publicationDate 2021-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-202144425-A
titleOfInvention Specific antigen binding molecule, preparation method and pharmaceutical use thereof
abstract Specific antigen binding molecule, preparation method and pharmaceutical use thereof. Concretely, the invention relates to anti-BCMA antibody, bispecific antigen binding molecule binding BCMA and CD3 and their use. Further, the invention relates to a chimeric antibody, a humanized antibody and bispecific antigen binding molecule binding BCMA and CD3 comprising a CDR region of the anti-BCMA antibody, medicine composition thereof, and use thereof as an anti-cancer medicament or treat autoimmune diseases. In particular, the invention relates to a bispecific antigen binding nmolecule binding BCMA and CD3, and the preparation of medicaments for BCMA - mediated diseases or conditions thereof.
priorityDate 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586860
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19593
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP71276
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70372
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08548
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4KTA7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ47526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415826292
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21935
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22316
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4922
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12395
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1PS67
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00939
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27ID4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8LKW0
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ94818
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO13339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SPU7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID608
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ94819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396493
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457585837
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ673L6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO76332
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV59
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9NBX4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ95SX7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV86
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV89
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO14746
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77448
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID127236
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV94
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6A548
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449812109
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06163
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21328
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23072
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452088256
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ46666
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21329
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396422

Total number of triples: 81.